血清心肌肌钙蛋白作为创伤性与非创伤性脑损伤患者预后标志物的荟萃分析
该研究系统检索多个数据库,纳入8项分析性研究、共2435例脑损伤患者(肌钙蛋白升高组916例,对照组1519例),评估肌钙蛋白升高(常规或高敏法检测)与死亡率的关系。汇总分析显示,肌钙蛋白升高与死亡率升高相关,总体OR 3.37(95%CI 2.13-5.36);创伤性脑损伤亚组OR 3.31(95%CI 1.99-5.53),非创伤性脑损伤亚组OR 3.36(95%CI 1.32-8.6)。作者认为肌钙蛋白升高在两类脑损伤中均与高死亡率显著相关,但需前瞻性临床试验支持这些发现并用于生物标志物风险分层。
要点
- 脑损伤患者肌钙蛋白升高与死亡率升高相关,总体汇总OR 3.37(95%CI 2.13-5.36)。
- 创伤性脑损伤亚组肌钙蛋白升高者死亡风险OR 3.31(95%CI 1.99-5.53)。
- 非创伤性脑损伤亚组肌钙蛋白升高者死亡风险OR 3.36(95%CI 1.32-8.6)。
- 共纳入8项分析性研究、2435例患者,肌钙蛋白升高组916例,对照组1519例。
- 作者认为需前瞻性临床试验支持这些发现并用于生物标志物风险分层。
适用人群与场景
- 创伤性脑损伤(TBI)患者
- 非创伤性脑损伤(NT-BI)患者
研究设计与关键结果
- 研究类型:系统综述与荟萃分析,纳入8项分析性研究(回顾性、前瞻性或随机临床试验或准随机试验)。
- 总样本量2435例,其中肌钙蛋白升高组916例,对照组1519例。
- 主要终点为死亡率:总体汇总OR 3.37(95%CI 2.13-5.36)。
- 创伤性脑损伤亚组死亡率汇总OR 3.31(95%CI 1.99-5.53)。
- 非创伤性脑损伤亚组死亡率汇总OR 3.36(95%CI 1.32-8.6)。
- 检索691篇参考文献,最终8项分析性研究符合纳入标准。
证据类型、等级与局限
- 证据类型:系统综述与荟萃分析。
- 作者结论:汇总分析提示肌钙蛋白升高与TBI和NT-BI患者高死亡率显著相关;需前瞻性临床试验支持这些发现并用于生物标志物风险分层。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肌钙蛋白升高在创伤性和非创伤性脑损伤患者中均与死亡率升高相关,但需前瞻性临床试验支持这些发现并用于生物标志物风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The association between brain injury and elevated serum cardiac troponin (cTn) remains poorly understood. We conducted a systematic review and meta-analysis to evaluate whether elevated cTn increases the risk of mortality in patients with traumatic (TBI) or non-traumatic brain injury (NT-BI).
METHODS: Cochrane Library, MEDLINE, PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), WHO International Clinical Trials Registry Platform, and Google scholar databases, and clinicaltrials.gov were searched for a retrospective, prospective and randomized clinical trials (RCT) or quasi-RCT studies that assessed the effect of elevated cTn (conventional or high sensitive assay) on the outcomes of brain injury patients. The main outcome of interest was mortality. Two authors independently abstracted the data using a data collection form. Results from different studies were pooled for analysis, whenever appropriate. The total number of patients pooled was 2435, of which 916 had elevated cTn and 1519 were in control group.
RESULTS: Out of 691 references identified through the search, 8 analytical studies met inclusion criteria. Among both types of brain injuries, an elevated cTn was associated with a higher mortality with an overall pooled odd ratio (OR) of 3.37 (95% CI 2.13-5.36). The pooled OR for mortality was 3.31 (95% CI 1.99-5.53) among patients with TBI and 3.36 (95% CI 1.32-8.6) among patients with NT-BI.
CONCLUSIONS: Pooled analysis indicates that elevated cTn is significantly associated with a high mortality in patients with TBI and NT-BI. Prospective clinical trials are needed to support these findings and to inform a biomarker risk stratification regardless of the mechanism of injury.
参考来源
- El-Menyar A, Sathian B, Wahlen BM, et al. Serum cardiac troponins as prognostic markers in patients with traumatic and non-traumatic brain injuries: A meta-analysis. Am J Emerg Med. 2018. PMID: 30318278. doi:10.1016/j.ajem.2018.10.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。